HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Nature Medicine2010Vol. 16(4), pp. 460–465
Citations Over TimeTop 1% of 2010 papers
María J. Buzón, Marta Massanella, Josep M. Llibre, Anna Esteve‐Codina, Viktor Dahl, María C. Puertas, Josep M. Gatell, Peré Domingo, Roger Paredes, Mark Sharkey, Sarah Palmer, Mario Stevenson, Bonaventura Clotet, Julià Blanco, Javier Martínez‐Picado
Related Papers
- Characterization and structural analysis of HIV-1 integrase conservation.(2009)
- → Evolution of Integrase Resistance During Failure of Integrase Inhibitor-Based Antiretroviral Therapy(2010)73 cited
- → Integrase inhibitors in the treatment of HIV-1 infection(2010)56 cited
- → Structural-Functional Analysis of 2,1,3-Benzoxadiazoles and Their N-oxides As HIV-1 Integrase Inhibitors(2013)22 cited
- → The HIV-1 integrase E157Q polymorphism per se does not alter susceptibility to raltegravir and dolutegravir in vitro(2017)14 cited